Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

United Therapeutics Corporation (UTHR)

  • Business News
  • Jan. 05, 2026, 12:05 UTC
  • 4
  • 1 comments

UTHR: United Therapeutics Corporation to Present at the 44th Annual J.P. Morgan Healthcare Conference

Market reaction Comment Full text

NeoGenomics Inc (NEO)

  • Business News
  • Jan. 05, 2026, 12:05 UTC
  • 3
  • 1 comments

NeoGenomics to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Market reaction Comment Full text

Bausch Health Companies Inc (BHC)

  • Business News
  • Jan. 05, 2026, 12:04 UTC
  • 3
  • 1 comments

Bausch Health Notification

Market reaction Comment Full text

United Therapeutics Corporation (UTHR)

  • Business News
  • Jan. 05, 2026, 12:04 UTC
  • 5
  • 1 comments

UTHR: Notification

Market reaction Comment Full text

Halozyme Therapeutics Inc (HALO)

  • Business News
  • Jan. 05, 2026, 12:02 UTC
  • 5
  • 1 comments

Halozyme - Halozyme and Skye Bioscience Announce Global Collaboration and License Agreement to Evaluate Nimacimab Co-Formulated withENHANZE® for Obesity

Market reaction Comment Full text

RedHill Biopharma (RDHL)

  • Business News
  • Jan. 05, 2026, 12:01 UTC
  • 5
  • 1 comments

RedHill Biopharma - RedHills RHB-102 Progresses in Multiple GI Indications Including GLP-1 Therapy-Related GI Side Effects

Market reaction Comment Full text

Natera Inc (NTRA)

  • Business News
  • Jan. 05, 2026, 12:00 UTC
  • 5
  • 1 comments

Natera - Natera Launches 21-Gene Fetal Focus™Single-Gene NIPT, Powered By Ultra-Sensitive LinkedSNP™Technology

Market reaction Comment Full text

KORU Medical Systems Inc (KRMD)

  • Business News
  • Jan. 05, 2026, 12:00 UTC
  • 5
  • 1 comments

KORU Medical Systems Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Market reaction Comment Full text

United Therapeutics Corporation (UTHR)

  • Business News
  • Jan. 05, 2026, 12:00 UTC
  • 6
  • 1 comments

United Therapeutics Corporation to Present at the 44th Annual J.P. Morgan Healthcare Conference

Market reaction Comment Full text

Marker Therapeutics Inc. (MRKR)

  • Business News
  • Jan. 05, 2026, 12:00 UTC
  • 4
  • 1 comments

Baylor College of Medicine Publishes Promising Safety and Efficacy Results of Multi-Antigen Targeted T Cells in Patients with Pancreatic Cancer

Market reaction Comment Full text
  • Previous
  • 182
  • 183
  • 184
  • 185
  • 186
  • Next

Search

News categories

  • Technical Exchange News(10877)
  • Event(2252)
  • SEC News(189201)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(124560)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin